medicare coverage glp 1 CMS has announced important updates to of GLP-1 medications for 2027. Instead of transitioning to the BALANCE Model, Medicare coverage for GLP-1 medications used for weight management will continue through GLP-1 Insurance Coverage Statistics 2026

Fifty of the 173 users discontinued the agents before the 1-year study period was up, most often for gastrointestinal symptoms and "insurance issues." Limitations to the study included its single-center, retrospective design and small sample size

The diverse roles of microglia in the neurodegenerative aspects of central nervous system (CNS) autoimmunity

Several excellent reviews are available on the mechanisms of AITD [examples are Ref

10.1016/j.ijrobp.2023.04.004 182 XiangP.ChenQ.ChenL.LeiJ.YuanZ.HuH.et al (2023)

On the other hand, K IR channels, activated by elevated external K + during neural activity, primarily mediate K + influx without causing cellular hyperpolarization [105]